{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:thiazide-and-thiazide-like-diuretics",
  "owner": "cardio",
  "kind": "drug",
  "slug": "thiazide-and-thiazide-like-diuretics",
  "name": "Thiazide and thiazide-like diuretics",
  "aliases": [
    "Thiazide diuretics",
    "Thiazide-like diuretics",
    "Thiazides"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "A group of diuretics used for high blood pressure and for swelling from fluid build-up. The US label read for hydrochlorothiazide, a thiazide, lists high blood pressure and fluid build-up from congestive heart failure. The label read for chlorthalidone, which the label says differs chemically from the thiazides, lists the same two uses, and the US drug record places it in a thiazide-like group.",
  "summary_technical": "Class page for a group made of two sets. MeSH descriptor D049993 (Sodium Chloride Symporter Inhibitors, last updated 2021-06-30) is a broad match: it is named for the mechanism, agents that inhibit sodium chloride symporters and act as diuretics, and it holds a concept for thiazide diuretics (Diuretics, Thiazide). The chemical descriptor D049971 (Thiazides) is not used as the match, because MeSH defines it as heterocyclic compounds, commonly the benzothiadiazines, so it does not cover the thiazide-like members. Two US labels were read: hydrochlorothiazide tablets (application ANDA202556, effective 2026-04-01 in openFDA; established pharmacologic class Thiazide Diuretic) and chlorthalidone tablets (application ANDA211627, effective 2022-11-24 in openFDA; established pharmacologic class Thiazide-like Diuretic). Both are generic labels, not the original brand. The hydrochlorothiazide label says the mechanism of the antihypertensive effect of thiazides is unknown. The label texts read state no age range for their uses. This page gives no dose, no trial result and no guideline statement; the pregnancy and other warnings in the labels were not recorded. Medicines of the group that have their own pages are filed under it.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-11-09",
  "last_evidence_check": "2026-11-09",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "mesh",
      "value": "D049993",
      "normalized_value": "D049993",
      "match": "broad",
      "version": "MeSH linked-data descriptor record fetched on 2026-11-09, lastUpdated 2021-06-30; the record states no yearly MeSH release",
      "label": "Sodium Chloride Symporter Inhibitors",
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "blood-vessels"
      ],
      "condition-area": [
        "hypertension"
      ]
    }
  },
  "payload": {
    "level": "class",
    "mechanism": "The hydrochlorothiazide label says the mechanism of the antihypertensive effect of thiazides is unknown, and that the medicine affects the distal renal tubular mechanism of electrolyte reabsorption."
  },
  "content_digest": "6efd2718f01e794731d09599c48c12e0fb7599e4d5fc85389bcf8fc94874c4bf",
  "review": {
    "content_digest": "6efd2718f01e794731d09599c48c12e0fb7599e4d5fc85389bcf8fc94874c4bf",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-thiazide-labels-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:thiazide-and-thiazide-like-diuretics",
      "category": "descriptive",
      "statement": "Two US generic labels were read. The label of hydrochlorothiazide tablets (Accord Healthcare Inc., application ANDA202556; the version dated 2026-04-01 in openFDA) calls the medicine a diuretic and antihypertensive and lists the management of hypertension and adjunctive therapy in edema associated with congestive heart failure. The label of chlorthalidone tablets (Unichem Pharmaceuticals (USA), Inc., application ANDA211627; the version dated 2022-11-24 in openFDA) calls the medicine a monosulfamyl diuretic that differs chemically from thiazide diuretics, and lists the management of hypertension and the same heart failure edema use. openFDA's records give the established pharmacologic class Thiazide Diuretic for the first label and Thiazide-like Diuretic for the second. MeSH says the thiazide term commonly refers to the benzothiadiazines used as diuretics. It files thiazide diuretics as a concept of the descriptor Sodium Chloride Symporter Inhibitors, agents that act as diuretics.",
      "context": {
        "id": "cardio:ctx-fda-thiazide-labels-us",
        "label": "People with hypertension or with edema from congestive heart failure, as described in two US labels of a thiazide and a thiazide-like diuretic",
        "recipient": "unknown",
        "population": "Patients described in the indications sections of the two labels: patients with hypertension, and patients with edema associated with congestive heart failure (among other causes the labels list).",
        "care_setting": "Prescription medicine, as described in the US labels",
        "geography": "United States (US drug labels)",
        "life_stage_note": "Not stated in the passages read",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Hypertension",
            "Edema associated with congestive heart failure"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what two US generic labels say. It is not a finding about how well either medicine works, and no trial result is recorded for it in this atlas. The pharmacologic class names come from openFDA's record of each label. The labels list other uses and a pregnancy statement that were not recorded; contraindications, other warnings, interactions and dosing were not recorded either. Labels change, and openFDA lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-11-09",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], INDICATIONS AND USAGE",
          "applicability_note": "Hydrochlorothiazide: hypertension and heart failure edema.",
          "snapshot": {
            "id": "cardio:openfda-label-hydrochlorothiazide-accord-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:39Z",
            "content_hash": "84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6",
            "source_effective_date": "2026-04-01",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-hydrochlorothiazide-accord",
            "source_type": "regulator",
            "title": "openFDA drug label record for hydrochlorothiazide tablets, Accord Healthcare Inc. label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22babb1b20-fe82-40ba-8e7a-0c56fe433b4a%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id babb1b20-fe82-40ba-8e7a-0c56fe433b4a (manufacturer Accord Healthcare Inc., application ANDA202556), returned on 2026-11-09. The label text is dated 2026-04-01 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-hydrochlorothiazide-accord.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].openfda.pharm_class_epc[0]",
          "applicability_note": "Established pharmacologic class in openFDA: Thiazide Diuretic.",
          "snapshot": {
            "id": "cardio:openfda-label-hydrochlorothiazide-accord-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:39Z",
            "content_hash": "84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6",
            "source_effective_date": "2026-04-01",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-hydrochlorothiazide-accord",
            "source_type": "regulator",
            "title": "openFDA drug label record for hydrochlorothiazide tablets, Accord Healthcare Inc. label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22babb1b20-fe82-40ba-8e7a-0c56fe433b4a%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id babb1b20-fe82-40ba-8e7a-0c56fe433b4a (manufacturer Accord Healthcare Inc., application ANDA202556), returned on 2026-11-09. The label text is dated 2026-04-01 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-hydrochlorothiazide-accord.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20260401.",
          "snapshot": {
            "id": "cardio:openfda-label-hydrochlorothiazide-accord-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:39Z",
            "content_hash": "84f40f21b1e0fc57063909f4dcab71d58f55ce6b6bb99055c663b27c106c11f6",
            "source_effective_date": "2026-04-01",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-hydrochlorothiazide-accord",
            "source_type": "regulator",
            "title": "openFDA drug label record for hydrochlorothiazide tablets, Accord Healthcare Inc. label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22babb1b20-fe82-40ba-8e7a-0c56fe433b4a%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id babb1b20-fe82-40ba-8e7a-0c56fe433b4a (manufacturer Accord Healthcare Inc., application ANDA202556), returned on 2026-11-09. The label text is dated 2026-04-01 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-hydrochlorothiazide-accord.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], INDICATIONS AND USAGE",
          "applicability_note": "Chlorthalidone: hypertension and heart failure edema.",
          "snapshot": {
            "id": "cardio:openfda-label-chlorthalidone-unichem-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:41Z",
            "content_hash": "5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630",
            "source_effective_date": "2022-11-24",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-chlorthalidone-unichem",
            "source_type": "regulator",
            "title": "openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2201065eda-7515-46bc-b858-a062c3aa35bd%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-chlorthalidone-unichem.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].description[0], DESCRIPTION",
          "applicability_note": "Chlorthalidone differs chemically from thiazide diuretics.",
          "snapshot": {
            "id": "cardio:openfda-label-chlorthalidone-unichem-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:41Z",
            "content_hash": "5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630",
            "source_effective_date": "2022-11-24",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-chlorthalidone-unichem",
            "source_type": "regulator",
            "title": "openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2201065eda-7515-46bc-b858-a062c3aa35bd%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-chlorthalidone-unichem.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].openfda.pharm_class_epc[0]",
          "applicability_note": "Established pharmacologic class in openFDA: Thiazide-like Diuretic.",
          "snapshot": {
            "id": "cardio:openfda-label-chlorthalidone-unichem-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:41Z",
            "content_hash": "5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630",
            "source_effective_date": "2022-11-24",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-chlorthalidone-unichem",
            "source_type": "regulator",
            "title": "openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2201065eda-7515-46bc-b858-a062c3aa35bd%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-chlorthalidone-unichem.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20221124.",
          "snapshot": {
            "id": "cardio:openfda-label-chlorthalidone-unichem-2026-11-09",
            "retrieved_at": "2026-11-09T13:17:41Z",
            "content_hash": "5cfb84ceb2ed66b3aa0c9b6a9ab0966fb7ac8c9623874762f484f79353a1b630",
            "source_effective_date": "2022-11-24",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-chlorthalidone-unichem",
            "source_type": "regulator",
            "title": "openFDA drug label record for chlorthalidone tablets, Unichem Pharmaceuticals (USA), Inc. label: indications and class description",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%2201065eda-7515-46bc-b858-a062c3aa35bd%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 01065eda-7515-46bc-b858-a062c3aa35bd (manufacturer Unichem Pharmaceuticals (USA), Inc., application ANDA211627), returned on 2026-11-09. The label text is dated 2022-11-24 (effective_time). Other openFDA records of labels for the same ingredient from other sponsors and repackagers exist and were not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/w4k03-openfda-label-chlorthalidone-unichem.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "scopeNote.@value",
          "applicability_note": "MeSH scope note: what the thiazide term refers to.",
          "snapshot": {
            "id": "cardio:mesh-scope-d049971-2026-11-09",
            "retrieved_at": "2026-11-09T13:15:44Z",
            "content_hash": "8f55829c320bca01d90bd277a7bba2f780bac3669a7cd29cf94af0e707c25da1",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:mesh-scope-d049971",
            "source_type": "dataset",
            "title": "MeSH scope note for descriptor D049971 (Thiazides)",
            "canonical_url": "https://id.nlm.nih.gov/mesh/M0471776",
            "identifiers": [
              {
                "scheme": "mesh",
                "value": "M0471776",
                "normalized_value": "M0471776",
                "match": "exact",
                "version": "id.nlm.nih.gov linked data, preferred concept of descriptor D049971, retrieved 2026-11-09",
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. National Library of Medicine",
            "edition": "MeSH linked-data record of the preferred concept M0471776 of descriptor D049971, fetched 2026-11-09. The scope note is on this concept record, not on the descriptor record.",
            "reuse_basis": "The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed at research/snapshots/w4k03-meshc-M0471776.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "scopeNote.@value",
          "applicability_note": "MeSH scope note of the matched descriptor: sodium chloride symporter inhibitors act as diuretics.",
          "snapshot": {
            "id": "cardio:mesh-scope-d049993-2026-11-09",
            "retrieved_at": "2026-11-09T14:42:14Z",
            "content_hash": "a43244ed8eef72fe5a73e6d72636c10c164cd63eb440860890bb960d19857b07",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:mesh-scope-d049993",
            "source_type": "dataset",
            "title": "MeSH scope note for descriptor D049993 (Sodium Chloride Symporter Inhibitors)",
            "canonical_url": "https://id.nlm.nih.gov/mesh/M0471877",
            "identifiers": [
              {
                "scheme": "mesh",
                "value": "M0471877",
                "normalized_value": "M0471877",
                "match": "exact",
                "version": "id.nlm.nih.gov linked data, preferred concept of descriptor D049993, retrieved 2026-11-09",
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. National Library of Medicine",
            "edition": "MeSH linked-data record of the preferred concept M0471877 of descriptor D049993, fetched 2026-11-09. The scope note is on this concept record, not on the descriptor record.",
            "reuse_basis": "The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed at research/snapshots/w4k03-meshc-M0471877.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "label.@value",
          "applicability_note": "MeSH concept of the matched descriptor named Diuretics, Thiazide.",
          "snapshot": {
            "id": "cardio:mesh-concept-m0006628-2026-11-09",
            "retrieved_at": "2026-11-09T14:42:23Z",
            "content_hash": "7119cc10d5b13289e5912295254fa99e0ea0c9a5ef96985ca56463f13bc7d0d4",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:mesh-concept-m0006628",
            "source_type": "dataset",
            "title": "MeSH concept M0006628 (Diuretics, Thiazide) of descriptor D049993 (Sodium Chloride Symporter Inhibitors)",
            "canonical_url": "https://id.nlm.nih.gov/mesh/M0006628",
            "identifiers": [
              {
                "scheme": "mesh",
                "value": "M0006628",
                "normalized_value": "M0006628",
                "match": "exact",
                "version": "id.nlm.nih.gov linked data, a non-preferred concept of descriptor D049993, retrieved 2026-11-09",
                "label": null,
                "from_source": false
              }
            ],
            "publication_date": null,
            "publisher": "U.S. National Library of Medicine",
            "edition": "MeSH linked-data record of concept M0006628, which descriptor D049993 lists among its concepts, fetched 2026-11-09. The descriptor record is its own source, cardio:mesh-d049993.",
            "reuse_basis": "The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. Source: National Library of Medicine. This copy was fetched on 2026-11-09 and may not reflect the most current data. The raw bytes are committed at research/snapshots/w4k03-meshc-M0006628.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "bba91b381938223bc11bbf363bb1a313dfda598949f4315ed2521d2629d01609",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-thiazide-labels-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "evaluated_for",
        "label": "Two US labels list managing high blood pressure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "core:hypertension",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-thiazide-labels-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "evaluated_for",
        "label": "Two US labels list fluid build-up from congestive heart failure as an indication",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:heart-failure",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-thiazide-labels-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "related_to",
        "label": "Blood pressure lowering medicine, the care strategy",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:bp-lowering-medicine",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Files under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:chlorthalidone",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-2409-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:hydrochlorothiazide",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-5487-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[2].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "Has subtype",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:indapamide",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-5764-2026-11-09",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[1].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01172431",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01172431-2014-06-24",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01647932",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01647932-2022-10-04",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02185417",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02185417-2024-05-22",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02841280",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02841280-2023-05-15",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03298802",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03298802-2026-07-14",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/thiazide-and-thiazide-like-diuretics/",
  "context_path": "api/v1/context/cardio--thiazide-and-thiazide-like-diuretics.md"
}
